MLL
IDXX icon

Moody Lynn & Lieberson’s Idexx Laboratories IDXX Stock Holding History

Moody Lynn & Lieberson’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Buy
7,272
+22
+0.3% +$12.3K 0.2% 63
2026
Q1 		$4.07M Sell
7,250
-5
-0.1% -$3.21K 0.23% 59
2025
Q4 		$4.91M Sell
7,255
-25
-0.3% -$17K 0.26% 52
2025
Q3 		$4.65M Buy
7,280
+49
+0.7% +$29.7K 0.25% 61
2025
Q2 		$3.88M Sell
7,231
-11
-0.2% -$5.26K 0.22% 69
2025
Q1 		$3.04M Hold
7,242
– – 0.2% 69
2024
Q4 		$2.99M Buy
7,242
+9
+0.1% +$3.95K 0.18% 72
2024
Q3 		$3.65M Hold
7,233
– – 0.23% 63
2024
Q2 		$3.52M Hold
7,233
– – 0.23% 65
2024
Q1 		$3.91M Buy
7,233
+30
+0.4% +$16.4K 0.26% 66
2023
Q4 		$4M Buy
7,203
+7
+0.1% +$3.29K 0.3% 60
2023
Q3 		$3.15M Sell
7,196
-12
-0.2% -$5.98K 0.27% 61
2023
Q2 		$3.62M Sell
7,208
-830
-10% -$398K 0.29% 63
2023
Q1 		$4.02M Buy
8,038
+15
+0.2% +$7.18K 0.36% 58
2022
Q4 		$3.27M Sell
8,023
-101
-1% -$39.2K 0.3% 68
2022
Q3 		$2.65M Hold
8,124
– – 0.26% 72
2022
Q2 		$2.85M Sell
8,124
-270
-3% -$110K 0.26% 74
2022
Q1 		$4.59M Sell
8,394
-1,429
-15% -$752K 0.34% 61
2021
Q4 		$6.47M Sell
9,823
-6,863
-41% -$4.31M 0.43% 55
2021
Q3 		$10.4M Buy
16,686
+4,011
+32% +$2.7M 0.78% 37
2021
Q2 		$8.01M Buy
12,675
+3,620
+40% +$2M 0.6% 50
2021
Q1 		$4.43M Sell
9,055
-781
-8% -$391K 0.37% 64
2020
Q4 		$4.92M Buy
9,836
+49
+0.5% +$21.9K 0.42% 61
2020
Q3 		$3.85M Sell
9,787
-65
-0.7% -$24K 0.38% 61
2020
Q2 		$3.25M Hold
9,852
– – 0.35% 64
2020
Q1 		$2.39K Sell
9,852
-82
-0.8% -$21.4K 0.33% 58
2019
Q4 		$2.59M Sell
9,934
-20,950
-68% -$5.52M 0.25% 85
2019
Q3 		$8.4M Buy
30,884
+20,745
+205% +$5.77M 0.94% 38
2019
Q2 		$2.79M Hold
10,139
– – 0.31% 68
2019
Q1 		$2.27M Sell
10,139
-81
-0.8% -$16.7K 0.26% 70
2018
Q4 		$1.9M Sell
10,220
-15,555
-60% -$3.19M 0.26% 74
2018
Q3 		$6.43M Sell
25,775
-2,741
-10% -$665K 0.68% 47
2018
Q2 		$6.21M Buy
28,516
+18,954
+198% +$3.91M 0.73% 44
2018
Q1 		$1.83M Buy
9,562
+2,562
+37% +$473K 0.22% 85
2017
Q4 		$1.31M Hold
7,000
– – 0.14% 94
2017
Q3 		$1.09M Hold
7,000
– – 0.13% 102
2017
Q2 		$1.13M Buy
+7,000
New +$1.14M 0.15% 93

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Moody Lynn & Lieberson's IDXX Position: Q2 2026 in Review

Moody Lynn & Lieberson increased its Idexx Laboratories (IDXX) stake by 0.3% in Q2 2026, buying an estimated $12.3K and bringing the position to 7,272 shares worth $3.83M. The position accounts for 0.2% of the portfolio, ranked #63.

Moody Lynn & Lieberson first reported a position in IDXX in Q2 2017 and has held it in 37 quarters since. The position peaked at $10.4M in Q3 2021. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Moody Lynn & Lieberson held 7,272 shares of Idexx Laboratories worth $3.83M as of Q2 2026.
  • Moody Lynn & Lieberson bought 22 Idexx Laboratories shares in Q2 2026, an estimated $12.3K.
  • Idexx Laboratories made up 0.2% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #63 holding.
  • Moody Lynn & Lieberson first reported a position in Idexx Laboratories in Q2 2017 and has held it in 37 quarters since.
  • Moody Lynn & Lieberson's Idexx Laboratories position peaked at $10.4M in Q3 2021.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.